One of the newly emerging rosacea treatments, botulinum toxin has captivated attention for its possible efficacy in delivering approximately 4 months of symptomatic relief. On August 2, 2010, the US FDA declared the acceptance of incobotulinumtoxinA (Xeomin®) to the treatment of Grown ups